Infected EBOLA carriers escape quarantine hospital in the Democratic Republic of Congo


Image: Infected EBOLA carriers escape quarantine hospital in the Democratic Republic of Congo

A new and growing Ebola outbreak is hitting the Democratic Republic of Congo, and additional concerns have been raised as three infected people escaped their quarantine hospital, potentially infecting countless others.

The three patients had been quarantined in the northwestern city of Mbandaka, a port city with a population of nearly 1.2 million. Two of the patients have passed away, while a third has been found alive and brought back to the hospital for observation. Medecins Sans Frontieres said that two of the escapees had been brought by their families to a church to pray.

World Health Organization Spokesman Tarik Jasarevic told ABC News that while the incident was very concerning, it isn’t unusual for people to wish to spend their final moments in their homes with loved ones. WHO staff is now redoubling its efforts to track down everyone who might have come into contact with these patients.

The problem is compounded by the fact that Ebola is so easily spread. Exposure to the body, fluids, or even personal items of someone who has died from the disease can spread it easily, something that not everyone there is aware of. The WHO is working with community and religious leaders to get the word out in hopes of keeping infections to a minimum.

Another challenge is the fact that traditional practices in the area don’t match up with health recommendations, particularly when it comes to funeral practices. In addition, some of the rural population does not believe in Ebola in the first place and has no faith in the ability of Western medicine to help.

Get more news like this without being censored: Get the Natural News app for your mobile devices. Enjoy uncensored news, lab test results, videos, podcasts and more. Bypass all the unfair censorship by Google, Facebook, YouTube and Twitter. Get your daily news and videos directly from the source! Download here.

Workers from the WHO and Oxfam are going door to door to let everyone know what hygienic precautions they can take to lower their chances of contracting the deadly disease. They’re also letting them know about symptoms to look out for, which include headache, muscle pain, fatigue, fever, diarrhea, vomiting, rash, and bleeding or bruising.

How far will the current outbreak spread?

Until recently, the current Ebola outbreak had been confined to the country’s rural areas, but it has now made its way to bigger cities like Mbandaka, where it has the potential to spread to many more people. The city’s location along the Congo River and its use as a transit hub is raising fears about just how far the outbreak could spread. The city of Kinshasa, which has a population of 10 million, is just downstream, and across the river is the Republic of the Congo’s capital, Brazzaville.

So far, 58 people have reported hemorrhagic fever symptoms in the country, although it’s likely that there are many more cases going unreported given the general mistrust of doctors in the country. Thirty cases have tested positive for Ebola, 14 are suspected, and 14 are considered probable. Some of the infected include health care workers. Twenty-two people have died so far in what is the country’s ninth outbreak since the deadly virus was first identified in 1976, and the outbreak only started earlier this month.

Experts have said that the outbreak has now reached a critical point, with the next few weeks indicating whether they’ll be able to keep the outbreak under control or if it will hit urban areas in full force. Health workers have a list of more than 600 people who are known to have come into contact with confirmed cases, and they are working hard to keep it from becoming a repeat of past outbreaks. One of the biggest Ebola outbreaks struck Guinea, Sierra Leone, and Liberia between 2013 and 2016, killing more than 11,300 people.

Sources for this article include:

DailyStar.co.uk

ABCNews.go.com

CBC.ca

For all book lovers please visit my friend’s website.
URL: http://www.romancewithbooks.com

Zika Infects Adult Neural Progenitors Too


A mouse study shows that the virus has tropism for adult proliferative neural progenitor cells and immature neurons.

Zika virus exposure in a mouse model can infect adult neural stem cells in the brain, leading to cell death and reduced proliferation.CELL STEM CELL, H. LI ET AL.Microcephaly and associated birth defects in babies born to mothers infected with the virus during pregnancy is considered the most serious consequence of the ongoing Zika outbreak. However, the increasing incidence of Guillain-Barré syndrome and other neuropathologies linked to the mosquito-borne and sexually transmissible pathogen indicate that Zika virus infection represents a risk to adults, as well.

A number of recent studies have investigated how Zika virus infects fetal brain cells. Working in mice, scientists at Rockefeller University in New York City and their colleagues elsewhere have now examined how Zika virus infection impacts adult brain cells. As it turns out, as it has for fetal neural progenitor cells, Zika virus has tropism for adult proliferative neural progenitor cells and immature neurons. The team’s results were published today (August 18) in Cell Stem Cell.

Zika virus infection can also induce apoptosis of adult neural progenitor cells in the anterior subventricular and subgranular zones of the mouse brain, the researchers reported.

The results of this mouse study show, “for the first time, that [Zika virus] can affect adult neurogenesis by increasing cell death in both adult neurogenic niches,” the anterior subventricular and subgranular zones,”Patricia Garcez, who studies neuoroplasticity at Brazil’s Federal University of Rio de Janeiro and was not involved in the work, wrote in an email to The Scientist. “Humans produce more than 700 neurons a day in adult hippocampus. . . . If the [neural] stem cells are depleted the effect would be long-lasting.”

While the findings “suggest that the virus has the potential to infect and destroy adult neural progenitor cells in . . . the adult mouse brain,” wrote Arnold Kriegstein, director of the University of California, San Francisco, School of Medicine’s developmental and stem cell biology program, they “do not shed light onhow the virus infects the adult cells.” This mechanism has yet to be uncovered.

The researchers worked with six-week-old mice triply deficient in interferon regulatory factor, which were infected by a single strain of Zika virus, and examined only once post-infection. “We limited our results to just this once strain of mice, this one strain of virus, and this one endpoint in order to have robust and quantitative results,” study coauthor Joseph Gleeson of Rockefeller University wrote in an email to The Scientist. “We used one of the strains of Zika that is known to cause human disease,” he added, “so the work is relevant to the current outbreak.”

As to whether the results in mice might translate to humans, Gleeson noted that “future research would require analysis of the stem cell populations as well as neurocognitive outcomes in adults following Zika infection.” Still, he wrote, it stands to reason that “some immunocompromised or even some healthy individuals might have reactions to Zika like we show in mice.”

Overall, said Kriegstein, who was not involved in the work, “this paper highlights the potential risk that Zika virus infection of adults might have unsuspected consequences—in at least some patients—that could affect brain function and behavior.”

Man flu is no myth say scientists, with ‘manly’ men more susceptible


Men with high levels of testosterone have a secret flaw – less effective immune systems, researchers have discovered

Man flu may not be a myth after all, as scientist have found that men with high levels of testosterone have a hidden flaw – weak immune systems.

The discovery could explain why men are more susceptible than women to a whole range of bacterial, viral, fungal and parasitic infections, researchers said.

It may also be the reason why men’s immune systems respond less strongly to vaccinations against influenza, yellow fever, measles and hepatitis, along with many other infectious diseases.

Those who take testosterone supplements in the quest to gain muscle meanwhile, could be making themselves more susceptible to illness.

“This is the first study to show an explicit correlation between testosterone levels, gene expression and immune responsiveness in humans,” said US lead scientist Professor Mark Davis, from Stanford University.

“It could be food for thought to all the testosterone-supplement takers out there.”

The researchers studied how the immune systems of 34 men and 53 women were stimulated by the flu vaccine.

The jab generated a bigger boost in protective antibodies in women, with further analysis revealing activity that, in high testosterone men, was associated with a weakened antibody response. Men with low testosterone were not affected the same way.

Testosterone’s anti-inflammatory properties may explain why it can weaken the immune system, said scientists writing in the journal Proceedings of the National Academy of Sciences.

Prof Davies said the reason why testosterone weakens the immune system yet boosts muscle power and aggression, may be linked to the man’s evolutionary role.

Men are more likely than women to suffer injuries from competitive encounters, as well as their traditional roles of hunting, defence and potentially dangerous physical work, Prof Davies said. The dampening down the immune system makes male less susceptible to a potentially fatal over-reaction to infections, especially those from wounds.

“Ask yourself which sex is more likely to clash violently with, and do grievous bodily harm to, others of their own sex,” Prof Davis added.

Zinc ‘starves’ deadly bacteria.


Australian researchers have found that zinc can ‘starve’ one of the world’s most deadly bacteria by preventing its uptake of an essential metal.

The finding, by infectious disease researchers at the University of Adelaide and The University of Queensland, opens the way for further work to design antibacterial agents in the fight against Streptococcus pneumoniae.

Streptococcus pneumoniae is responsible for more than one million deaths a year, killing children, the elderly and other vulnerable people by causing pneumonia, meningitis, and other serious infectious diseases.

Published in the journal Nature Chemical Biology, the researchers describe how zinc “jams shut” a protein transporter in the bacteria so that it cannot take up manganese, an essential metal that Streptococcus pneumoniae needs to be able to invade and cause disease in humans.

“It’s long been known that zinc plays an important role in the body’s ability to protect against bacterial infection, but this is the first time anyone has been able to show how zinc actually blocks an essential pathway causing the bacteria to starve,” says project leader Dr Christopher McDevitt, Research Fellow in the University of Adelaide’s Research Centre for Infectious Diseases.

“This work spans fields from chemistry and biochemistry to microbiology and immunology to see, at an atomic level of detail, how this transport protein is responsible for keeping the bacteria alive by scavenging one essential metal (manganese), but at the same time also makes the bacteria vulnerable to being killed by another metal (zinc),” says Professor Bostjan Kobe, Professor of Structural Biology at The University of Queensland.

The study reveals that the bacterial transporter (PsaBCA) uses a ‘spring-hammer’ mechanism to bind the metals. The difference in size between the two metals, manganese and zinc, causes the transporter to bind them in different ways. The smaller size of zinc means that when it binds to the transporter, the mechanism closes too tightly around the zinc, causing an essential spring in the protein to unwind too far, jamming it shut and blocking the transporter from being able to take up manganese.

“Without manganese, these bacteria can easily be cleared by the immune system,” says Dr McDevitt. “For the first time, we understand how these types of transporters function. With this new information we can start to design the next generation of antibacterial agents to target and block these essential transporters.”

C difficile: Obesity Linked to Community-Onset Infections.


Obesity may be a risk factor for Clostridium difficile infection (CDI), according to results from a retrospective cohort study of 132 cases seen at a tertiary care medical center.

After potential confounders were taken into account, patients with simple community-onset infections were more than 4 times as likely to be obese as patients who had community-onset infections that came shortly after an exposure to a healthcare facility, according to data reported in an article published in the November issue ofEmerging Infectious Diseases.

“Obesity may be associated with CDI, independent of antibacterial drug or health care exposures,” write the researchers, led by Jason Leung, MD, from the University of Michigan Hospital in Ann Arbor. Such an association could help explain the uptick of community-onset cases in individuals having low levels of traditional risk factors.

The authors propose that obesity may perturb the intestinal microbiome in ways similar to those seen with inflammatory bowel disease and use of antibiotics, both of which are known risk factors for CDI.

“Translational research could help elaborate the dimensions of the interaction of the intestinal microbiota with C. difficile in obese patients,” the researchers maintain. They also suggest that an investigation of a dose–response relationship between body mass index and infection risk might be informative.

“[I]t is critical to establish whether obesity is a risk factor for high rates of C. difficile colonization, as is [inflammatory bowel disease]; if that risk factor is established, prospective observations would improve understanding of whether obesity plays a role in the acquisition of CDI, or alters severity of disease and risk for recurrence,” they write.

As for the patients with community-onset infections after healthcare exposure, the study’s findings highlight “the importance of increased infection control at ancillary health care facilities and surveillance for targeting high-risk patients who were recently hospitalized.”

In the study, the researchers reviewed the microbiology results and medical records of all patients who had laboratory-proven, nonrecurrent CDI at Boston Medical Center in Massachusetts during a 6-month period.

When the patients were classified according to the setting of disease onset, 43% had infections that began in the community without recent exposure to a healthcare facility, 30% had infections that began in a healthcare facility, and 23% had infections that began in the community within 30 days of exposure to a healthcare facility (most often a hospital or long-term care facility).

The prevalence of obesity, defined as a body mass index exceeding 30 kg/m2, was 34% in the group with community-onset infections compared with 23% in the general population (odds ratio, 1.7; 95% confidence interval [CI], 1.02 – 2.99). The value stood at 13% in the group with community-onset healthcare-associated infections and 32% in the group with healthcare-onset infections.

In multivariate analyses, patients with simple community-onset infections were significantly less likely to be older than 65 years (odds ratio, 0.35; 95% CI, 0.13 – 0.92; P < .05) and more likely to be obese (odds ratio, 4.06; 95% CI, 1.15 – 14.36; P < .05) than patients with community-onset healthcare-associated infections.

In addition, patients with simple community-onset infections were significantly less likely to have prior antibiotic exposure (odds ratio, 0.29; 95% CI, 0.11 – 0.76; P < .05) than patients with healthcare-onset infections. There was also a trend whereby they were much more likely to have inflammatory bowel disease (odds ratio, 6.40; 95% CI, 0.73 – 56.17; P < .10).

Finally, patients with community-onset healthcare-associated infections were dramatically less likely to have had prior antibiotic exposure than patients with healthcare-onset infections (odds ratio, 0.08; 95% CI, 0.02 – 0.28; P < .05).

Narrow-Spectrum Antibiotics Effective for Pediatric Pneumonia.


Narrow-spectrum antibiotics have similar efficacy and cost-effectiveness as broad-spectrum antibiotics in the treatment of pediatric community-acquired pneumonia (CAP), according to the findings of a retrospective study.

Derek J Williams, MD, MPH, from Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues published their findings online October 28 in Pediatrics.

“The 2011 Pediatric Infectious Diseases Society/Infectious Diseases Society of America…guideline for the management of children with [CAP] recommends narrow-spectrum antimicrobial therapy for most hospitalized children,” the authors write. “Nevertheless, few studies have directly compared the effectiveness of narrow-spectrum agents to the broader spectrum third-generation cephalosporins commonly used among hospitalized children with CAP.”

Therefore, the researchers used the Pediatric Health Information System database to assess the hospital length of stay (LOS) and associated healthcare costs of children aged 6 months to 18 years who were diagnosed with pneumonia between July 2005 and June 2011 and treated with either narrow-spectrum or broad-spectrum antibiotics. The authors excluded children with potentially severe pneumonia, those at risk for healthcare-associated infections, and those with mild disease requiring less than 2 days of hospitalization.

Narrow-spectrum therapy consisted of the exclusive use of penicillin or ampicillin, whereas broad-spectrum treatment was defined as the exclusive use of parenteral ceftriaxone or cefotaxime.

The median LOS for the entire study population (n = 15,564) was 3 days (interquartile range, 3 – 4 days), and LOS was not significantly different between the narrow-spectrum and broad-spectrum treatment groups (adjusted difference [aD], 0.12 days; P = .11), after adjustments for covariates including age, sex, and ethnicity.

Similarly, the investigators found no differences in the proportion of children requiring intensive care unit admission in the first 2 days of hospitalization (adjusted odds ratio [aOR], 0.85; 95% CI, 0.25 – 2.73) or hospital readmission within 14 days (aOR, 0.85; 95% CI, 0.45 – 1.63) were noted between the groups.

Narrow-spectrum treatment was also linked to a similar cost of hospitalization (aD, −$14.4; 95% CI, −$177.1 to $148.3) and cost per episode of illness (aD, −$18.6; 95% CI, −$194 to $156.9) as broad-spectrum therapy.

The researchers note that the limitations of the study were mostly related to its retrospective nature, including potential confounding by indication, the absence of etiologic and other clinical data, and a relative lack of objective outcome measures.

“Clinical outcomes and costs for children hospitalized with CAP are not different when empirical treatment is with narrow-spectrum compared with broad-spectrum therapy,” the authors write. “Programs promoting guideline implementation and targeting judicious antibiotic selection for CAP are needed to optimize management of childhood CAP in the United States.”

Antibiotics for All but Very Mild C difficile.


On October 29, the European Society of Clinical Microbiology and Infection (ESCMID) issued updated guidelines for Clostridium difficile infection (CDI), reviewing treatment options of antibiotics, toxin-binding resins and polymers, immunotherapy, probiotics, and fecal or bacterial intestinal transplantation. The new recommendations, published online October 5 in Clinical Microbiology and Infection, advise antibiotic treatment for all but very mild cases of CDI.

CDI, which is potentially fatal, is now the leading cause of healthcare-acquired infections in hospitals, having surpassed methicillin-resistant Staphylococcus aureus.

“[A]fter the recent development of new alternative drugs for the treatment of CDI (e.g. fidaxomicin) in US and Europe, there has been an increasing need for an update on the comparative effectiveness of the currently available antibiotic agents in the treatment of CDI, thereby providing evidence-based recommendations on this issue,” write Sylvia B. Debast, from the Centre for Infectious Diseases, Leiden University Medical Center The Netherlands, and colleagues from the ESCMID Committee.

The new guideline, which updates the 2009 ESCMID recommendations now used widely in clinical practice, summarizes currently available CDI treatment options and offers updated treatment recommendations on the basis of a literature search of randomized and nonrandomized trials.

The ESCMID and an international team of experts from 11 European countries developed recommendations for different patient subgroups, including initial nonsevere disease, severe CDI, first recurrence or risk for recurrent disease, multiple recurrences, and treatment of CDI when patients cannot receive oral antibiotics.

Antibiotic Recommended in Most Cases

Specific recommendations include the following:

·         For nonepidemic, nonsevere CDI clearly induced by antibiotic use, with no signs of severe colitis, it may be acceptable to stop the inducing antibiotic and observe the clinical response for 48 hours. However, patients must be monitored very closely and treated immediately for any signs of clinical deterioration.

·         Antibiotic treatment is recommended for all cases of CDI except for very mild CDI, which is actually triggered by antibiotic use. Suitable antibiotics include metronidazole, vancomycin, and fidaxomicin, a newer antibiotic that can be given by mouth.

·         For mild/moderate disease, metronidazole is recommended as oral antibiotic treatment of initial CDI (500 mg 3 times daily for 10 days).

·         Fidaxomicin may be used in all CDI patients for whom oral antibiotic treatment is appropriate. Specific indications for fidaxomicin may include first-line treatment in patients with first CDI recurrence or at risk for recurrent disease, in patients with multiple recurrences of CDI, and in patients with severe disease and nonsevere CDI.

These recommendations were based on 2 large phase 3 clinical studies that compared 400 mg/day oral fidaxomicin with 500 mg/day oral vancomycin, the standard of care. The rate of CDI recurrence was lower with fidaxomicin, but the cure rate was similar for both treatments.

·         For severe CDI, suitable oral antibiotic regimens are vancomycin 125 mg 4 times daily (may be increased to 500 mg 4 times daily) for 10 days, or fidaxomicin 200 mg twice daily for 10 days.

·         In life-threatening CDI, there is no evidence supporting the use of fidaxomicin.

·         In severe CDI or life-threatening disease, the use of oral metronidazole is strongly discouraged.

·         For multiple recurrent CDI, fecal transplantation is strongly recommended.

·         Total abdominal colectomy or diverting loop ileostomy combined with colonic lavage is recommended for CDI with colonic perforation and/or systemic inflammation and deteriorating clinical condition despite antibiotic treatment.

·         Additional measures for CDI management include discontinuing unnecessary antimicrobial therapy, adequate fluid and electrolyte replacement, avoiding antimotility medications, and reviewing proton pump inhibitor use.

Polio Eradication by the Numbers.


http://www.ozy.com/acumen/polio-eradication-by-the-numbers/3274.article#b10g24f20b13

New mosquito repellent is ultra-effective – Australian Geographic


A new vapour developed in the USA renders humans virtually undetectable to mozzies.

SCIENTISTS HAVE CREATED WHAT might be the most effective insect repellent ever.

While the majority of existing repellents create an odour that is unpleasant for mosquitos, using a yellow oil known as DEET, this new blend of chemicals renders the insect senseless.

“These chemicals make you invisible,” says Dr Ulrich Bernier, a research chemist at the United States Department of Agriculture research service, and creator of the new formula.

Most effective mosquito repellent?

With over 5000 reported cases of mosquito-borne Ross River and Barmah Forest viruses in Australia every year, this new formula could prove to be invaluable for Australians in rural and urban areas.

Mosquitoes find humans by honing in on various chemicals and bacteria on the skin. In 2000, while studying this process, Ulrich created a repellent consisting of several chemicals, all of which are found in low doses in the human body. The resulting repellent was somewhat effective.

Years later, Ulrich added additional chemicals to the formula, including homopiperazine and 1-methylhomopiperazine, similar to those found in the human body, which acted to mask the scent of humans. He was amazed by the results.

“We took a cage of mosquitoes and gave them two ports to fly into: one with human hands inserted into them, and the other one with nothing.” At first, Ulrich explains, the mosquitoes were attracted to the container with the human hands. After the repellent was sprayed, however, they approached the containers with equal interest.

Researchers are keeping close guard over the ingredients of the formula, which was patented last year.

Repellent in vapour form

Significantly, this new repellent will be sprayed into the air, as opposed to directly on the skin.

Dr Cameron Webb, a medical entomologist at Sydney University, says that while DEET-based sprays have proven to be adequate in preventing mosquito bites, this new development represents an important next-step in insect-borne disease control.

“When applying lotions or sprays onto the skin, one can easily miss a spot,” says Cameron. “Air-based repellents solve that issue.”

The new repellent will take the form of a vapour which will work to create a protective bubble. While DEET has been accepted as a safe means of repellent, Ulrich says it’s always safer to have chemicals further away from humans.

Commercial availability is still a ways off, however: Ulrich says more field tests and toxicology tests are necessary to ensure the product is completely safe before it can hit the market.

Beat Back Cold and Flus with… Garlic.


Story at-a-glance

  • Garlic has long been hailed for its healing powers, especially against infectious diseases like cold and flu. It has immune boosting effects, and fresh garlic is also a potent antibacterial, antiviral and anti-fungal agent
  • Studies have demonstrated more than 150 beneficial health effects of garlic, including reducing your risk for heart disease, high cholesterol and high blood pressure, and various cancers such as brain, lung and prostate cancer
  • Research has shown that those taking garlic daily for three months had fewer colds than those who took a placebo, and, when they did come down with a cold, the duration of illness was shorter
  • Garlic must be used fresh to give you optimal health benefits. To stimulate the process that catalyzes the formation of allicin, compress a fresh clove with a spoon prior to swallowing it, or put it through your juicer with other veggies.

garlic

If you want a simple way to increase the disease-fighting power of your meals, be generous with your use of high-quality herbs and spices. This applies year-round, but as cold and flu season nears, you may want to consider spicing things up more than you might normally.

There is no shortage of research showing that herbs and spices are among the healthiest you can consume. And they’re a “secret weapon” that just about everyone can take advantage of, regardless of your budget.

Garlic in particular has long been hailed for its healing powers, especially against infectious diseases like cold and flu.

This is likely due to its immune boosting effects. Fresh garlic is also a potent antibacterial, antiviral and anti-fungal agent. But its therapeutic effects may go much further than that.

Garlic—An All-Around Health Boosting Herb

The featured article in Medical News Today1 contains an impressive list of garlic’s historical use as a natural medicine, and modern research to back up the wisdom of such antiquated claims. Green Med Info has also assembled a list of studies demonstrating more than 150 beneficial health effects of garlic! For example, studies show that regular consumption of (primarily raw) garlic:

·         May be effective against drug-resistant bacteria

·         Reduces risk for heart disease,2 including heart attack3 and stroke

·         Helps normalize your cholesterol4 and blood pressure

·         Protects against cancer,5, 6 including brain,7 lung,8 and prostate9 cancer

·         Reduces risk of osteoarthritis10

It’s thought that much of garlic’s therapeutic effect comes from its sulfur-containing compounds, such as allicin, which are also what give it its characteristic smell. Other health-promoting compounds include oligosaccharides, arginine-rich proteins, selenium and flavonoids.11

Research12 has revealed that as allicin digests in your body, it produces sulfenic acid, a compound that reacts with dangerous free radicals faster than any other known compound.

This is one of the reasons why I named garlic as one of the top seven anti-aging foods you can consume. Garlic is also a triple threat against infections, offering antibacterial, antiviral and antifungal properties.

Not only is it effective at killing antibiotic-resistant bacteria, including MRSA, but it also fights yeast infections, viruses and parasites. Garlic must be fresh to give you optimal health benefits though.

The fresh clove must be crushed or chopped in order to stimulate the release of an enzyme called alliinase, which in turn catalyzes the formation of allicin.13Allicin in turn rapidly breaks down to form a number of different organosulfur compounds. So to “activate” garlic’s medicinal properties, compress a fresh clove with a spoon prior to swallowing it, or put it through your juicer to add to your vegetable juice.

A single medium size clove or two is usually sufficient, and is well-tolerated by most people. The active ingredient, allicin, is destroyed within one hour of smashing the garlic, so garlic pills are virtually worthless.

You also won’t reap all the health benefits garlic has to offer if you use jarred, powdered or dried versions. Worse yet, at least two supermarket-brands containing garlic powder imported from China have been found to be contaminated with high levels of lead, arsenic and added sulfites, according to a recent article by PreventDisease.com.14

If you develop a socially offensive odor, just decrease the amount of garlic you’re consuming until there is no odor present. If garlic makes you feel ill, this is probably your body’s way of letting you know you should avoid it.

Garlic versus Tamiflu

Garlic may be particularly useful in preparation for cold and flu season, as it contains compounds capable of killing a wide variety of organisms, including viruses and bacteria that can cause earaches, colds and influenza. The respected research organization Cochrane Database—which has repeatedly reported that the science does not support the use of flu vaccine as a first-line defense—has also reviewed studies on the alternatives, such as the use of garlic.15

They found that those who took garlic daily for three months had fewer colds than those who took a placebo, and, when they did come down with a cold, the duration of illness was shorter—an average of 4.5 days compared to 5.5 days for the placebo group.

While this may not seem overly impressive, it’s still better than the results achieved by the much-advertised flu drug Tamiflu. If taken within 48 hours of onset of illness, Tamiflu might reduce the duration of flu symptoms by about a day to a day and a half. That’s the extent of what this $100-plus treatment will get you. It’s virtually identical to just taking garlic on a regular basis!

However, some patients with influenza are at increased risk for secondary bacterial infections when on Tamiflu—a risk you won’t take by eating garlic… Other adverse events of Tamiflu include pediatric deaths, serious skin reactions, and neuropsychiatric events, including suicide committed while delirious.

Cold and Flu—Symptoms of Vitamin D Deficiency

While colds and flus are caused by viral infections, compelling research suggests that your ability to “catch” these infections may actually be a symptom of an underlying vitamin D deficiency. Vitamin D is a potent antimicrobial agent, producing 200 to 300 different antimicrobial peptides in your body that kill bacteria, viruses and fungi. Suboptimal vitamin D levels will significantly impair your immune response, thereby making you far more susceptible to contracting colds, influenza, and other respiratory infections.

In the largest and most nationally representative study16 of its kind to date, involving about 19,000 Americans, people with the lowest vitamin D levels reported having significantly more recent colds or cases of the flu — and the risk was even greater for those with chronic respiratory disorders like asthma. At least five additional studies also show an inverse association between lower respiratory tract infections and vitamin D levels.

The best source for vitamin D is direct sun exposure. While it may not be possible to get enough sun exposure during the winter, every effort should be made to attain vitamin D from UVB exposure as there are many additional benefits from this route other than vitamin D. The next best option to sunlight is the use of a safe indoor tanning device. As a last resort, if neither natural nor artificial sunlight is an option, you may taken an oral vitamin D3 supplement. However, if you do, you need to be aware of the following:

·         Make sure you’re taking the correct vitamin D supplement. You want D3, not D2, as the latter may end up doing more harm than good.

·         Based on the latest research from GrassrootsHealth, the average adult dose required to reach vitamin D levels of about 40 ng/ml is around 8,000 IU’s of vitamin D3 per day. For children, many experts agree they need about 35 IU’s of vitamin D per pound of body weight.

·         Get your vitamin D serum level checked at regular intervals to make sure you’re taking the appropriate dose to get within the therapeutic range of 50-70 ng/ml.

·         If you’re taking high dose vitamin D supplements you also need to take vitamin K2—not K1 that is typically in vegetables as it will not work synergize with vitamin D. Vitamin K2 deficiency is actually what produces the symptoms of vitamin D toxicity, which includes inappropriate calcification that can lead to hardening of your arteries. The reason for this is when you take vitamin D, your body creates more vitamin K2-dependent proteins that shuttle the calcium into the appropriate areas. Without vitamin K2, those proteins remain inactivated, so the benefits of those proteins remain unrealized.

Four Factors That Undermine Your Immune System

Again, it’s important to remember that both colds and various influenzas are caused by a wide variety of viruses, not bacteria. Hence, taking an antibiotic for your cold or flu will NOT do you any good whatsoever. Antibiotics only work on bacterial infections, such as sinus, ear and lung infections, including bronchitis and pneumonia. The latter two are potential secondary infections that can develop from a serious bout of cold or flu, so you do want to keep an eye out for signs and symptoms of such bacterial infections.

At the end of this article, you’ll find some guidelines to help you decide when it would be prudent to see a doctor.

Now, the most common way cold and flu viruses are spread is via hand-to-hand contact, so the easiest way to cut down your risk is to frequently wash your hands (see next section below). However, the key to remember is that being exposed to a cold virus does not mean that you’re destined to get sick. Again, whether or not you’ll actually get sick is primarily dependent on the functioning of your immune system. If your immune system is operating at its peak, it should actually be quite easy for you to fend off the virus without ever getting sick.

As discussed above, vitamin D deficiency is a major factor that will depress your immune function, leaving the door open to invading viruses. Other lifestyle factors that can depress your immune system, alone or in combination, include:

·         Eating too much sugar/fructose and grains. Sugar in all its forms takes a heavy toll on your immune system. One of the ways it does this is by unbalancing your gut flora. Sugar is “fertilizer” for pathogenic bacteria, yeast, and fungi that can set your immune system up for an assault by a respiratory virus. Remember, 80 percent of your immune system lies in your gastrointestinal tract, which is why limiting your sugar intake is CRUCIAL for optimizing your immune system.

It would be wise to limit your total fructose consumption to below 25 grams a day if you’re in good health, or below 15 grams a day if you have high blood pressure, diabetes, heart disease, or are insulin resistant or are trying to recover from an acute illness like the flu.

·         Lack of sleep. If you aren’t getting enough restorative sleep, you’ll be at increased risk for a hostile viral takeover. Your immune system is also the most effective when you’re not sleep-deprived, so the more rested you are the quicker you’ll recover. You can find 33 guidelines for a better night’s sleep here.

·         Insufficient exercise. Regular exercise is a crucial strategy for increasing your resistance to illness. There is evidence that regular, moderate exercise can reduce your risk for respiratory illness by boosting your immune system. In fact, one study17 found that people who exercised regularly (five or more days a week) cut their risk of having a cold by close to 50 percent. And, in the event they did catch a cold, their symptoms were much less severe than among those who did not exercise.

Exercise likely cuts your risk of colds so significantly because it triggers a rise in immune system cells that can attack any potential invaders. Each time you exercise you can benefit from this boost to your immune system. It can also help boost your immune system acutely, by increasing your body temperature. This helps kill off invading pathogens, similarly to the fever your body produces when sick.

·         Using ineffective strategies to address stress. Emotional stressors can also predispose you to an infection while making cold symptoms worse. Finding ways to manage daily stress as well as your reactions to circumstances beyond your control will contribute to a strong and resilient immune system. Effective strategies include a variety of energy psychology tools, such as the Emotional Freedom Technique (EFT).

Other All-Natural Strategies That Send Pathogens Packin’

Frequently washing your hands with soap and water is one of the easiest ways to wipe out germs and viruses and reduce your chances of becoming sick. Don’t make the mistake of using antibacterial cleansers, as their widespread use contributes to strains of resistant bacteria, or “superbugs” that render antibiotics useless. Besides, research18 has shown that people who use antibacterial soaps and cleansers often develop a cough, runny nose, sore throat, fever, vomiting, diarrhea and other symptoms just as often as people who use plain soap and water. There’s no real justification for using an antibacterial soap when plain soap is safer, and just as effective.

Another strategy that many report success with is to administer a few drops of 3% hydrogen peroxide (H2O2) into your ear canal. Quite frequently, people claim to have been able to cure a cold or flu within 12 to 14 hours this way. Simply put a few drops into your ear; wait until the bubbling and stinging subside (usually 5 to 10 minutes), then drain onto a tissue and repeat with the other ear.

There are also a number of supplements and simple treatments that can be beneficial for colds and influenza, but I believe they should only be used as adjuncts to an otherwise healthy diet and lifestyle. For detailed instructions that will help set you the right path can be found in my optimized nutrition and lifestyle plan. Some of the more helpful options for cold and flu—besides vitamin D and garlic discussed above–include:

Zinc: Research on zinc has shown that when taken within one day of the first symptoms, zinc can cut down the time you have a cold by about 24 hours. Zinc was also found to greatly reduce the severity of symptoms. Suggested dosage: up to 50 mg/day. Zinc was not recommended for anyone with an underlying health condition, like lowered immune function, asthma or chronic illness.

Vitamin C: A very potent antioxidant; use a natural form such as acerola, which contains associated micronutrients. You can take several grams every hour till you are better unless you start developing loose stools.

Olive leaf extract: Ancient Egyptians and Mediterranean cultures used it for a variety of health-promoting uses and it is widely known as a natural, non-toxic immune system builder.

Propolis: A bee resin and one of the most broad-spectrum antimicrobial compounds in the world; propolis is also the richest source of caffeic acid and apigenin, two very important compounds that aid in immune response.

Oregano Oil: The higher the carvacrol concentration, the more effective it is. Carvacrol is the most active antimicrobial agent in oregano oil.

Medicinal mushrooms, such asshiitake, reishi, and turkey tail.

A tea made from a combination of elderflower, yarrow, boneset, linden, peppermint and ginger;drink it hot and often for combating a cold or flu. It causes you to sweat, which is helpful for eradicating a virus from your system.

Echinacea is one of the most widely used herbal medications in Europe to combat colds and infections. One review of more than 700 studies found that using Echinacea can reduce your risk of catching cold by as much as 58 percent.

When Should You Call Your Physician?

Generally speaking, if you have a cold, medical care is not necessary. Rest and attention to the lifestyle factors noted above—particularly the admonition to avoid sugar—will help you to recover quickly and, if you stick to them, will significantly reduce your chances of catching another cold anytime soon.

Getting back to garlic for a moment, a previous article by PreventDisease.com19 gives instructions for a garlic soup that can help destroy most viruses and help you recover a little quicker. Ideally though, you’d want to incorporate immune-boosting diet- and lifestyle strategies as soon as possible to prevent illness in the first place.

So, when should you call your doctor?

Sinus, ear, and lung infections such as bronchitis and pneumonia CAN be bacterial however, and if so, may respond to antibiotics. If you develop any of the following symptoms, these are signs you may be suffering from a bacterial infection rather than a cold, and you should call your physician’s office:

·         Fever over 102 degrees Fahrenheit (38.9 degrees Celsius)

·         Ear pain

·         Pain around your eyes, especially with a green nasal discharge

·         Shortness of breath or a persistent uncontrollable cough

·         Persistently coughing up green and yellow sputum